4.6 Article

Differential impact on motor unit characteristics across severities of adult spinal muscular atrophy

Related references

Note: Only part of the references are listed.
Review Computer Science, Information Systems

K-means clustering algorithms: A comprehensive review, variants analysis, and advances in the era of big data

Abiodun M. Ikotun et al.

Summary: Advances in data collection techniques have enabled the accumulation of large quantities of data. The K-means algorithm, while popular, has challenges such as determining the number of clusters and detecting non-Euclidean shapes. Research efforts have been made to improve its performance and robustness.

INFORMATION SCIENCES (2023)

Article Neurosciences

Intrinsic motor neuron excitability is increased after resistance training in older adults

Lucas B. R. Orssatto et al.

Summary: This study examined the effects of high-intensity resistance training on motor neuron persistent inward current (PIC) estimates in older adults. The results showed that PIC amplitudes increased after resistance training, resulting in increased motor neuron discharge rates and improvements in strength and functional capacity. These findings suggest that increased motor neuron excitability mediated by enhanced PIC amplitudes is a potential mechanism underlying the benefits of resistance training in older adults.

JOURNAL OF NEUROPHYSIOLOGY (2023)

Review Clinical Neurology

Nusinersen in Adults with 5q Spinal Muscular Atrophy: a Systematic Review and Meta-analysis

Maria Gavriilaki et al.

Summary: This systematic review and meta-analysis examined the efficacy and safety of nusinersen in patients older than 12 years with 5q spinal muscular atrophy (5q-SMA). The results showed significant improvements in motor function and upper limb function in patients, but no changes in walking ability and pulmonary function. Despite the low quality of evidence, the study confirmed that nusinersen is a valuable treatment option for adult 5q-SMA patients.

NEUROTHERAPEUTICS (2022)

Article Clinical Neurology

Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study

C. Lefeuvre et al.

Summary: This study retrospectively collected data from wheelchair-bound adults with spinal muscular atrophy and found that Nusinersen treatment did not significantly improve motor function or lung function. However, there were significant improvements in performance and satisfaction scores based on the Canadian Occupational Performance Measure in some patients.

REVUE NEUROLOGIQUE (2022)

Review Rehabilitation

Systematic Review of Motor Function Scales and Patient-Reported Outcomes in Spinal Muscular Atrophy

Jennifer W. Wu et al.

Summary: This article systematically reviewed the utility and limitations of motor function scales and patient-reported outcomes in evaluating patients with spinal muscular atrophy. The study identified 15 commonly used motor function scales and patient-reported outcomes, each with its own strengths and limitations. When selecting appropriate assessment tools, it is important to consider the patient population, treatment goals, and outcomes of interest.

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2022)

Article Biochemistry & Molecular Biology

Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy

Laura H. Comley et al.

Summary: Spinal muscular atrophy (SMA) is a childhood motor neuron disease caused by anomalies in the SMN1 gene. Restoration of Smn levels can reduce neuromuscular junction pathology, but the recovery is incomplete. This study is of great significance for improving the treatment effect.

HUMAN MOLECULAR GENETICS (2022)

Article Clinical Neurology

Detecting motor unit abnormalities in amyotrophic lateral sclerosis using high-density surface EMG

Yuichi Nishikawa et al.

Summary: This study detected specific motor unit (MU) abnormalities in people with amyotrophic lateral sclerosis (ALS) using high-density surface electromyography (HD-SEMG). The results showed that ALS patients had abnormal MU firing behavior compared to controls, and these abnormalities were correlated with disease severity.

CLINICAL NEUROPHYSIOLOGY (2022)

Article Clinical Neurology

Nusinersen treatment of older children and adults with spinal muscular atrophy

Chamindra G. Konersman et al.

Summary: This study aimed to determine the effectiveness of nusinersen in improving motor function in older adolescent and adult patients with spinal muscular atrophy. Results showed that older patients receiving nusinersen treatment experienced improvements in motor function, with stabilized symptoms and incremental progress observed over the study period.

NEUROMUSCULAR DISORDERS (2021)

Review Genetics & Heredity

Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis

Giorgia Coratti et al.

Summary: This review critically examined real-world data on motor function in SMA patients treated with Nusinersen, finding positive changes in the treated group compared to negative changes in the untreated group.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Medicine, General & Internal

Risdiplam in Type 1 Spinal Muscular Atrophy

Giovanni Baranello et al.

Summary: In a study involving 21 infants with type 1 spinal muscular atrophy, treatment with oral risdiplam resulted in increased levels of functional SMN protein in the blood. Infants in the high-dose group were more likely to sit without support for at least 5 seconds, and the higher dose of risdiplam was selected for the second part of the study.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Clinical Neurology

Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMA

Bakri Elsheikh et al.

Summary: The study found that nusinersen treatment is safe and well-tolerated in ambulatory adults with spinal muscular atrophy, resulting in improved motor function and muscle strength. The 6-min walk test showed significant increases at 2, 6, and 10 months post-treatment, while the maximal voluntary isometric muscle contraction testing demonstrated stability.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy

Bakri Elsheikh et al.

Summary: The study investigated the safety, tolerability, and treatment effect of nusinersen in non-ambulatory adults with SMA. The results showed that nusinersen treatment, including C1/C2 delivery, was overall safe and well-tolerated. Although motor outcomes remained stable, there were increases in motor unit and CMAP size observed.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Motor unit number estimation in adult patients with spinal muscular atrophy treated with nusinersen

Christian Schneider et al.

Summary: The study evaluated the organization and short-term changes of motor units in adult patients with spinal muscular atrophy (SMA) treated with nusinersen, finding significantly lower motor unit numbers in patients with SMA and a moderate to strong correlation between electrophysiological measures and clinical scores.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen

Didu Kariyawasam et al.

Summary: The study showed that intrathecal nusinersen treatment in children with symptomatic spinal muscular atrophy increased CMAP, MUNE, and N50, with a greater impact seen in children with shorter disease durations. This suggests that nusinersen therapy may improve functional innervation in SMA by promoting recovery of smaller motor units, potentially providing insights for novel targets in disease modification for motor neuropathies.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Review Medicine, Research & Experimental

Update on Biomarkers in Spinal Muscular Atrophy

Megan G. Pino et al.

Summary: The availability of disease modifying therapies for spinal muscular atrophy (SMA) has created a need to identify clinically meaningful biomarkers, which can provide insight into disease progression and reveal biologic, physiologic, or pharmacologic phenomena occurring prior to clinical detection. Efforts to identify such biomarkers have resulted in the discovery of various molecular and physiologic markers that can evaluate biological media or nervous system function, with some showing potential for predicting disease severity and treatment response.

BIOMARKER INSIGHTS (2021)

Article Clinical Neurology

Nusinersen Treatment in Adults With Spinal Muscular Atrophy

Tina Duong et al.

Summary: This study evaluated changes in motor and respiratory function in adults with spinal muscular atrophy (SMA) following treatment with nusinersen over a two-year period. The results showed significant improvements in various motor and respiratory measures in participants, suggesting the efficacy of nusinersen in treating SMA. All participants tolerated nusinersen well with no significant adverse events reported.

NEUROLOGY-CLINICAL PRACTICE (2021)

Article Clinical Neurology

Assessment of motor unit loss in patients with spinal muscular atrophy

Boudewijn T. H. M. Sleutjes et al.

CLINICAL NEUROPHYSIOLOGY (2020)

Article Clinical Neurology

Outcome measures in a cohort of ambulatory adults with spinal muscular atrophy

Bakri Elsheikh et al.

MUSCLE & NERVE (2020)

Article Clinical Neurology

Motor unit number index in children with later-onset spinal muscular atrophy

Sumit Verma et al.

MUSCLE & NERVE (2020)

Article Clinical Neurology

Abnormal motor unit firing rates in chronic inflammatory demyelinating polyneuropathy

Kevin J. Gilmore et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)

Article Clinical Neurology

Muscle strength and motor function in adolescents and adults with spinal muscular atrophy

Camiel A. Wijngaarde et al.

NEUROLOGY (2020)

Article Clinical Neurology

Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3

Lorenzo Maggi et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Article Clinical Neurology

Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report

V. A. Sansone et al.

JOURNAL OF NEUROMUSCULAR DISEASES (2020)

Article Clinical Neurology

Revised upper limb module for spinal muscular atrophy: 12 month changes

Maria Carmela Pera et al.

MUSCLE & NERVE (2019)

Review Clinical Neurology

Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy

Didu S. T. Kariyawasam et al.

FRONTIERS IN NEUROLOGY (2019)

Article Medicine, Research & Experimental

Biomarker definitions and their applications

Robert M. Califf

EXPERIMENTAL BIOLOGY AND MEDICINE (2018)

Article Clinical Neurology

The motor unit number index (MUNIX) profile of patients with adult spinal muscular atrophy

Giorgia Querin et al.

CLINICAL NEUROPHYSIOLOGY (2018)

Article Physiology

Age-related differences in the motor unit action potential size in relation to recruitment threshold

Adam J. Sterczala et al.

CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2018)

Review Clinical Neurology

Safety and pain in electrodiagnostic studies

Zachary N. London

MUSCLE & NERVE (2017)

Article Clinical Neurology

REVISED UPPER LIMB MODULE FOR SPINAL MUSCULAR ATROPHY: DEVELOPMENT OF A NEW MODULE

Elena S. Mazzone et al.

MUSCLE & NERVE (2017)

Article Medicine, General & Internal

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy

J. R. Mendell et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

R. S. Finkel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, Research & Experimental

Rate Coding and the Control of Muscle Force

Roger M. Enoka et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)

Article Clinical Neurology

High-density surface electromyography provides reliable estimates of motor unit behavior

E. Martinez-Valdes et al.

CLINICAL NEUROPHYSIOLOGY (2016)

Article Engineering, Electrical & Electronic

Characterization of Human Motor Units From Surface EMG Decomposition

Dario Farina et al.

PROCEEDINGS OF THE IEEE (2016)

Article Rehabilitation

A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research

Terry K. Koo et al.

JOURNAL OF CHIROPRACTIC MEDICINE (2016)

Article Clinical Neurology

A Large Animal Model of Spinal Muscular Atrophy and Correction of Phenotype

Sandra I. Duque et al.

ANNALS OF NEUROLOGY (2015)

Article Neurosciences

Decomposition of surface EMG signals from cyclic dynamic contractions

Carlo J. De Luca et al.

JOURNAL OF NEUROPHYSIOLOGY (2015)

Article Multidisciplinary Sciences

Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II/III spinal muscular atrophy

Laurent P. Bogdanik et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Clinical Neurology

SPINAL MUSCULAR ATROPHY: DIAGNOSIS AND MANAGEMENT IN A NEW THERAPEUTIC ERA

W. David Arnold et al.

MUSCLE & NERVE (2015)

Article Neurosciences

Error reduction in EMG signal decomposition

Joshua C. Kline et al.

JOURNAL OF NEUROPHYSIOLOGY (2014)

Article Clinical Neurology

THE MOTOR NEURON RESPONSE TO SMN1 DEFICIENCY IN SPINAL MUSCULAR ATROPHY

Peter B. Kang et al.

MUSCLE & NERVE (2014)

Article Clinical Neurology

Electrophysiological biomarkers in spinal muscular atrophy: proof of concept

W. David Arnold et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)

Article Biochemistry & Molecular Biology

Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of > 72 400 specimens

Elaine A. Sugarman et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2012)

Article Neurosciences

Hierarchical control of motor units in voluntary contractions

Carlo J. De Luca et al.

JOURNAL OF NEUROPHYSIOLOGY (2012)

Article Biophysics

Preferred sensor sites for surface EMG signal decomposition

Farah Zaheer et al.

PHYSIOLOGICAL MEASUREMENT (2012)

Article Clinical Neurology

Multipoint incremental motor unit number estimation as an outcome measure in ALS

J. M. Shefner et al.

NEUROLOGY (2011)

Article Clinical Neurology

High-yield decomposition of surface EMG signals

S. Hamid Nawab et al.

CLINICAL NEUROPHYSIOLOGY (2010)

Article Biophysics

Filtering the surface EMG signal: Movement artifact and baseline noise contamination

Carlo J. De Luca et al.

JOURNAL OF BIOMECHANICS (2010)

Article Rehabilitation

MEASUREMENT OF MUSCLE STRENGTH WITH A HANDHELD DYNAMOMETER IN PATIENTS WITH CHRONIC SPINAL MUSCULAR ATROPHY

Anna Febrer et al.

JOURNAL OF REHABILITATION MEDICINE (2010)

Review Clinical Neurology

Clinical Outcome Measures in Spinal Muscular Atrophy

Jacqueline Montes et al.

JOURNAL OF CHILD NEUROLOGY (2009)

Review Neurosciences

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Arthur H. M. Burghes et al.

NATURE REVIEWS NEUROSCIENCE (2009)

Article Neurosciences

Decomposition of surface EMG signals

Carlo J. De Luca et al.

JOURNAL OF NEUROPHYSIOLOGY (2006)

Article Clinical Neurology

Natural history of denervation in SMA:: Relation to age, SMN2 copy number, and function

KJ Swoboda et al.

ANNALS OF NEUROLOGY (2005)

Review Psychology, Clinical

The use and reporting of cluster analysis in health psychology: A review

J Clatworthy et al.

BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2005)

Article Clinical Neurology

Outcome measures for pediatric spinal muscular atrophy

ST Iannaccone

ARCHIVES OF NEUROLOGY (2002)

Article Clinical Neurology

Reliability of hand-held dynamometry in spinal muscular atrophy

L Merlini et al.

MUSCLE & NERVE (2002)

Article Clinical Neurology

Motor unit number estimation in infants and children with spinal muscular atrophy

MB Bromberg et al.

MUSCLE & NERVE (2002)

Article Clinical Neurology

Depletion and sizes of motor units in spinal muscular atrophy

V Galea et al.

MUSCLE & NERVE (2001)